Furthermore, EPLIN has been described as a tumour suppressor, as the downregulation of EPLIN and induced deregulation of downstream participants results in promotion of cellular functions and the EMT process in multiple cancer types15–23. This evidence concerns the gene LIMA1 and neoplasm.